Thomas F Karam sold $1.5M of EQT
director at EQT Corp. 30,844 shares at an average of $48.74, traded Mar 11, 2025, filed Mar 12, 2025.
Score components
- +15RoleDirector
- +25Trade size$1.5M at market
- +10Share of holdings soldSold 45% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-007795, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 11, 2025 | SOpen-market sale Common Stock | -30,844 | $48.74 | $1.5M | 37,551 | Mar 12, 2025 |
Related signals
Other insiders at EQT Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | EQTsell EQT Corp | J.E.B. Bolen EVP OPERATIONS | $75k 1,422 shares | -2% | |
| 55Moderate | EQT Corp | Vicky A Bailey director | $220k 4,259 shares | -100% | |
| 53Moderate | EQT Corp | Sarah Fenton EVP UPSTREAM | $646k 12,438 shares | -48% | |
| 37Weak | EQTsell EQT Corp | Jeremy Knop CHIEF FINANCIAL OFFICER | $368k 7,216 shares | -6% | |
| 45Moderate | EQTsell EQT Corp | Thomas F Karam director | $2.1M 45,922 shares | -20% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.